Page results
-
A new scan could improve how millions of people with high blood pressure are treated, suggests a new study led by UCL and conducted at UCLH.
-
The National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, is the UK's largest dedicated neurological and neurosurgical hospital. It provides comprehensive services for the diagnosis, treatment and care of all conditions that affect the brain, spinal cord, peripheral nervous system and muscles. Services include specialist neurosurgery, a brain tumour unit, the Hyper-acute Stroke Unit (HASU), an acute brain injury unit, the National Prion Clinic, a pioneering neuro-rehabilitation unit, the UK's first interventional MRI scanner, the largest specialised neurosurgical ITU and the only neuromedical ITU in the country. Together with its neighbour, the UCL Queen Square Institute of Neurology, it is a major international centre for research and training.
-
The National Hospital for Neurosurgery at Cleveland Street opened its doors to patients on 4 April 2016. This brand new centre was developed to provide a new home for our Pain Management Centre, a nationally recognized centre of excellence for people with longstanding pain. Set over two floors the centre has group rooms and consulting clinic rooms as well as procedure rooms.Some multiple sclerosis clinics and outpatient appointments for the National Prion Clinic are also held at the centre.
-
Information for patients from overseas visiting UCLH hospitals.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
-
Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with mesothelioma, a rare and aggressive cancer of the lining of the lung.
-
A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.
File results
-
FOI/2021/0417 - A&E attendance for carbon monoxide poisoning
-
FOI/2021/0419 - Sexual orientation workforce
-
FOI/2021/0426 - CAMHS treatment
-
FOI/2021/0430 - Neurorehabilitation
-
FOI/2021/0431 - Data Security and Protections Toolkit
-
FOI/2021/0433 - Breathing circuits and filters
-
FOI/2021/0438 - Dermatology service costs and contract values
-
FOI/2021/0440 - Windows 7 and XP in operation
-
FOI/2021/0441 - Unvacinated Covid inpatients
-
FOI/2021/0442 - Cataract surgery